busulfan has been researched along with Bilirubinemia in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperbilirubinemia was graded according to a report by Hogan et al (Blood." | 1.33 | Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases. ( Fujiwara, M; Hori, A; Kami, M; Kanda, Y; Komatsu, T; Koyama, R; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Seki, K; Tanaka, Y; Taniguchi, S; Wake, A; Yuji, K, 2006) |
| "Patients with multiple myeloma (MM) and chronic renal failure have generally been excluded from myeloablative therapy programs followed by hematopoietic stem cell support because of the potential increase in transplant-related morbidity and mortality." | 1.31 | Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure. ( Benni, M; Cavo, M; Motta, MR; Rizzi, S; Ronconi, S; Tosi, P; Tura, S; Zamagni, E, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kusumi, E | 1 |
| Kami, M | 1 |
| Kanda, Y | 2 |
| Murashige, N | 1 |
| Seki, K | 1 |
| Fujiwara, M | 1 |
| Koyama, R | 1 |
| Komatsu, T | 1 |
| Hori, A | 1 |
| Tanaka, Y | 1 |
| Yuji, K | 1 |
| Matsumura, T | 1 |
| Masuoka, K | 1 |
| Wake, A | 1 |
| Miyakoshi, S | 1 |
| Taniguchi, S | 1 |
| Stockschläder, M | 1 |
| Kalhs, P | 1 |
| Peters, S | 1 |
| Zeller, W | 1 |
| Krüger, W | 1 |
| Kabisch, H | 1 |
| Lechner, K | 1 |
| Zander, A | 1 |
| Akiyama, H | 1 |
| Tanikawa, S | 1 |
| Sakamaki, H | 1 |
| Sasaki, T | 1 |
| Takamoto, S | 1 |
| Onozawa, Y | 1 |
| Tosi, P | 1 |
| Zamagni, E | 1 |
| Ronconi, S | 1 |
| Benni, M | 1 |
| Motta, MR | 1 |
| Rizzi, S | 1 |
| Tura, S | 1 |
| Cavo, M | 1 |
1 trial available for busulfan and Bilirubinemia
| Article | Year |
|---|---|
Etoposide with/without G-CSF with busulfan and cyclophosphamide as conditioning for bone marrow transplantation. The BMT Team.
Topics: Adolescent; Adult; Bone Marrow; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Drug Admini | 1996 |
3 other studies available for busulfan and Bilirubinemia
| Article | Year |
|---|---|
Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Busulfan; Chemical and Drug In | 2006 |
Intravenous pentoxifylline failed to prevent transplant-related toxicities in allogeneic bone marrow transplant recipients.
Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Child; Cyclophosphami | 1993 |
Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Busulfan; | 2000 |